Google+ Facebook Twitter Twitter

IBMS responds to Dame Sally's report

The IBMS has issued a response to Professor Dame Sally Davies’ annual report, which calls on the government to develop genomic medicine’s role in the NHS.

Sarah May, IBMS Deputy Chief Executive, commented on Dame Sally’s focus on genomic testing.

“We support the Chief Medical Officer’s view that DNA testing should become standard across cancer care,” she said. 

“The UK has a workforce of highly skilled and trained biomedical scientists that are preparing to meet this new diagnostic and treatment challenge.” 

She added that the IBMS is launching two new molecular pathology qualifications in 2017. 

These are “intended to directly support the new and expanding science and technology and help to achieve Dame Sally’s vision for personalised diagnosis and healthcare”.

Related Articles

Crowd of people

Improving the health of future generations

Parmesher Singh explains the work that is being undertaken at UK Biobank and the impact that it is hoped to have.

Genomes DNA sequence

The 100,000 Genomes Project: it's not just about DNA

Gerry Thomas, Professor of Molecular Pathology, casts a critical eye over the 100,000 Genomes Project.*

Future antibiotics

Effective future antibiotics

Tuberculosis and other life-threatening microbial diseases could be more effectively tackled with future drugs.

Maturation of human sperm

New research sheds light on the complex process that occurs in the development of human sperm stem cells.